The Dow's Biggest Losers

Mr. Market to January: Let the good times keep rolling. The second trading day of 2012 saw two of three major indices up, while gold stayed above $1,600 an ounce and oil sat at $103 a barrel. For those who subscribe to "the January effect," the belief that a positive first month of an election year bodes well for the remaining 11 months, these first days are important. In fact, going back to 1945 a strong January has predicted solid annual market returns 86% of the time.

With that in mind, it is encouraging that not even negative news emanating from the E.U. could rattle the Dow Jones Industrial Average (INDEX: ^DJI) into a negative day, as it ended up 21 points. The S&P 500 also closed up but managed a meager 0.02% gain. The Nasdaq ended up down by an even more meager margin, 0.01%.

The good times didn't keep rolling for everyone, though. Inside the Dow, the single biggest decliner was Verizon (NYS: VZ) , down 1.3% on news that the company doubled iPhone sales in the fourth quarter but suffered a 6% reduction in gross margins, largely because of the discounts the company offered with smartphones. CFO Fran Shammo also denied that Verizon has any interest in buying Netflix (NAS: NFLX) , claiming that if anything, the company was looking for revenue-sharing partnerships. Netflix shares were up 11%, however, on increased speculation that other tech giants might be interested in acquiring the company.

Rounding out our bottom three we have Wal-Mart (NYS: WMT) and Pfizer (NYS: PFE) . Despite no news, Wal-Mart gave away all of its gains from yesterday, falling 1% to less than $60 a share. Pfizer declined 0.9%, where the only company-specific news was a $45 million verdict against the company and the loss of an executive to Illumina. Perhaps better feelings about the overall markets are causing money to move out of health-care stocks and into less defensive categories.

All told, it appears the market is continuing a positive trend to kick off the year. It's worth watching with a close eye to see how the market closes this week and this month -- and to see whether past trends remain true.

And while we're discussing coming trends, our top analysts have identified the best way to profit from The Next Trillion-Dollar Revolution. Download this must-read special free report right now, and don't miss your opportunity for truly market-beating returns.

At the time this article was published David Williamsonowns shares of Pfizer, but he holds no other position in any company mentioned. Check out hisholdings and a short bio. The Motley Fool owns shares of Wal-Mart Stores.Motley Fool newsletter serviceshave recommended buying shares of Wal-Mart Stores, Illumina, Pfizer, and Netflix and creating a diagonal call position in Wal-Mart Stores. Try any of our Foolish newsletter servicesfree for 30 days. We Fools don't all hold the same opinions, but we all believe thatconsidering a diverse range of insightsmakes us better investors. The Motley Fool has adisclosure policy.

Copyright © 1995 - 2012 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Read Full Story

Can't get enough business news?

Sign up for Finance Report by AOL and get everything from retailer news to the latest IPOs delivered directly to your inbox daily!

Subscribe to our other newsletters

Emails may offer personalized content or ads. Learn more. You may unsubscribe any time.